About
Offices
Professional Directory
Industries
Practice Areas
Resource Library
News & Events
Careers
Contact Us
Practice Areas »
Eckert Seamans practices are driven by client service. Organized across industry sectors as well as traditional legal fields, our practices are fully integrated to provide comprehensive legal services to clients.
Eckert Seamans
Food & Drug Administration Regulatory

The experienced Food & Drug Administration (FDA) Regulatory Group attorneys at Eckert Seamans counsel and advise clients on food, drug, biologic, and medical device development as well as other regulatory matters that are subject to the jurisdiction of the FDA. Obtaining FDA approval and launching new products into the market can present a daunting array of challenges and opportunities. Eckert Seamans’ FDA Regulatory team has developed an integrated approach that enables clients to achieve and maintain regulatory compliance while developing and marketing FDA-regulated products.

Eckert Seamans’ FDA Regulatory Group attorneys counsel companies before the FDA and its counterpart authorities abroad in all phases of the product development cycle, including strategic business planning, product development and testing, submissions, product marketing, regulatory compliance and enforcement and advertisement and promotion. Our attorneys have in-depth experience representing clients who are impacted by FDA regulations from concept through completion, including:

  • Strategic Business Planning;
  • Product Testing and Clinical Research;
  • Application Submissions and Negotiation;
  • Marketing FDA-Approved Products;
  • Regulatory Compliance and Enforcement Matters;
  • Regulation of Emerging Technologies at Home and Abroad;
  • Domestic and International Chemical Control and Hazardous Waste Regulation;
  • International Trade and Strategic Advice.

Clients we represent include FDA-regulated industries such as clinical research facilities, and manufacturers, processors, and distributors of:

  • Pharmaceuticals and Biologic/Biotech Drugs — both prescription and over-the-counter (OTC);
  • Food and Dietary Supplements;
  • Medical Devices.

Further, our practice focuses on issues arising under the Hatch-Waxman Act, such as market exclusivity periods, patent listing and certification requirements, 505(b)(2) issues and bioequivalence standards. Our FDA regulatory lawyers work closely with our patent and antitrust lawyers to provide an integrated approach to important life cycle management issues.

Our commitment to high-quality service means we do more than address the immediate legal issues at hand—we create complete solutions to help clients meet their most crucial business goals.

Primary Contacts
Mark C. Levy
Philadelphia, PA

View All Attorneys in
Practice Area




Back to Top
Eckert Seamans
Print this page    Email this page
* Member firms of Lex Mundi and SCG Legal practice independently and not in a relationship for the joint practice of law. View Legal Disclaimer | Privacy Statement | Sitemap
©2013, Eckert Seamans Cherin & Mellott, LLC. All Rights Reserved